University of Minnesota
Effect of Vasculotropic Dutch Amyloid Beta 40 on Blood-Brain Barrier (BBB) Endothelial Trafficking and Signaling
Abstract
dc:description.abstractCerebrovascular pathology, characterized by blood-brain barrier (BBB) dysfunction, is one of the pathological changes observed in the Alzheimer’s disease (AD) brain1. The BBB disruption is likely caused by the accumulation of amyloid beta (Aβ) peptides in the media and adventitia of cerebral arteries and arterioles, which results in a condition commonly referred to as cerebral amyloid angiopathy (CAA)². The CAA is associated with 80% of AD patients and results from the failure of Aβ peptide elimination. The two most common isoforms of Aβ often implicated in AD are Aβ40 and Aβ42. While Aβ42 accumulates in the brain parenchyma as amyloid plaques, Aβ40 accumulates predominantly in the cerebral vasculature as amyloid deposits3. Other mutant forms of Aβ40, such as Dutch (E22Q) and Iowa (D694N) Aβ40, tend to accumulate preferentially in cerebral vessels more readily than native Aβ40. Impaired clearance could be one potential reason behind this differential effect. Nevertheless, the molecular mechanisms underlying how these mutant forms preferentially accumulate in the cerebral vasculature and cause degeneration of the extracellular matrix are poorly understood. The impaired clearance of Aβ peptides leads to their accumulation in the BBB endothelium and triggers BBB dysfunction. Hence, in this thesis, polarized hCMEC/D3 monolayers were used to study the signaling mechanism involved in the clearance of Aβ40 and D-Aβ40. The expression of RAGE, an influx receptor that mediates the transport of Aβ from plasma to the brain, increased upon exposure to Aβ peptides. Other mechanisms that impact Aβ accumulation include oxidative stress, cerebrovascular inflammation, and impaired insulin signaling. The D-Aβ40 treatment, compared to Aβ40, significantly decreased the expression of the antioxidant marker TRX-1, leading to increased oxidative stress. Endothelial cells respond to this oxidative stress stimulus, leading to inflammation, which is evident in increased p-STAT3 expression. As both Aβ40 and D-Aβ40 accumulate across the vasculature, they interact with the basement membrane (BM). Insulin signaling regulates the composition of BM, and Aβ peptides disrupt this. Both D-Aβ40 and Aβ40 differentially affected the insulin signaling pathway, which regulates the expression of BM proteins such as Tissue inhibitors of matrix metalloproteases (TIMP) proteins. Impairment of the TIMP pathway leads to dysregulation of BM turnover and facilitates Aβ accumulation in the basement membrane. As Aβ40 and D-Aβ40 differentially affect RAGE and BM proteins, it is imperative that the clearance patterns of both peptides are different in BBB endothelial cells. The associated signaling mechanisms that promote the deposition of these peptides in the cerebrovascular basement membrane are responsible for CAA. Keywords: CAA, AD, Dutch Aβ40, Aβ40, BBB, Oxidative stress, Clearance
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Guttha, Vineetha
Subjects
dc:subject × 6Rights
- Language dc:language.iso
- en
Identifiers
dc:identifier.*- Dc Identifier Citation
- Guttha, Vineetha. (2025). Effect of Vasculotropic Dutch Amyloid Beta 40 on Blood-Brain Barrier (BBB) Endothelial Trafficking and Signaling. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/280351.